<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0210516</article-id>
<article-id pub-id-type="publisher-id">PONE-D-18-24520</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Cerebrovascular diseases</subject><subj-group><subject>Stroke</subject><subj-group><subject>Ischemic stroke</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Stroke</subject><subj-group><subject>Ischemic stroke</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Metaanalysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Metaanalysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Ultrasound imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Imaging techniques</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Ultrasound imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Radiology and imaging</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Ultrasound imaging</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hemorrhage</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hemorrhage</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Hemorrhage</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular anatomy</subject><subj-group><subject>Blood vessels</subject><subj-group><subject>Arteries</subject><subj-group><subject>Cerebral arteries</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Cardiovascular anatomy</subject><subj-group><subject>Blood vessels</subject><subj-group><subject>Arteries</subject><subj-group><subject>Cerebral arteries</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Cerebrovascular diseases</subject><subj-group><subject>Stroke</subject><subj-group><subject>Hemorrhagic stroke</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Vascular medicine</subject><subj-group><subject>Stroke</subject><subj-group><subject>Hemorrhagic stroke</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Efficacy and safety of sonothombolysis versus non-sonothombolysis in patients with acute ischemic stroke: A meta-analysis of randomized controlled trials</article-title>
<alt-title alt-title-type="running-head">Sonothombolysis in acute ischemic stroke</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Zhouqing</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Software</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Xue</surname>
<given-names>Tao</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Huang</surname>
<given-names>Huachen</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Xu</surname>
<given-names>Jiayi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Shankar</surname>
<given-names>Sandhya</given-names>
</name>
<role content-type="http://credit.casrai.org/">Validation</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Yu</surname>
<given-names>Hao</given-names>
</name>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7342-0845</contrib-id>
<name name-style="western">
<surname>Wang</surname>
<given-names>Zhong</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Project administration</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Neurosurgery &amp; Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Neurology, First affiliate Hospital, Harbin Medical University, Harbin, Heilongjiang Province, China</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Department of Neurosurgery, The First People’s Hospital of Nantong city, Nantong, Jiangsu Province, China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Toscano</surname>
<given-names>Massimiliano</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Universita degli Studi di Roma La Sapienza, ITALY</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">wangzhong761@163.com</email> (ZW); <email xlink:type="simple">ichsah@163.com</email> (HY)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>9</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>14</volume>
<issue>1</issue>
<elocation-id>e0210516</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>12</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2019</copyright-year>
<copyright-holder>Chen et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0210516"/>
<abstract>
<p>Recent studies have shown that inconsistent results of safety and efficacy between sonothombolysis vs. non-sonothombolysis in acute ischemic stroke (AIS). We implemented a meta-analysis to explore the value of sonothrombolysis in AIS treatment. The MEDLINE, EMBASE, and Cochrane Library databases were searched for randomized controlled trials (RCTs) which had evaluated sonothrombolysis or ultrasound thrombolysis in AIS. One hundred five studies were retrieved and analyzed, among them, 7 RCTs were included in the current meta-analysis. In comparison with the non-sonothombolysis, sonothrombolysis significantly improved complete recanalization (RR 2.16, 95% CI 1.51 to 3.08, <italic>P</italic> &lt; 0.001), complete or partial recanalization (RR 1.90, 95% CI 1.26 to 2.88, <italic>P</italic> = 0.002), there is also a tendency to improvement of ≥ 4 points in NIHSS score (RR 1.43, 95% CI 0.99 to 2.07, <italic>P</italic> = 0.057). However, sonothrombolysis and non-sonothrombolysis had insignificant differences in neurological recovery and adverse events. In subgroup analysis, we found that “With t-PA”, “NIHSS &gt; 15”, “Treatment time ≤ 150min”, and “Age ≤ 65 years” are potential favorable factors for efficacy outcomes of sonothombolysis. Sonothrombolysis can significantly increase the rate of recanalization in patients with AIS compared with non-sonothrombolysis, but there is no significant effect on improving neurological functional recovery and avoiding complications.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>No.81571115</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7342-0845</contrib-id>
<name name-style="western">
<surname>Wang</surname>
<given-names>Zhong</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This study was supported by the National Natural Science Foundation of China (No.81571115).</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<page-count count="15"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the manuscript and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Stroke, along with cardiac disease and cancer are the most common reasons for permanent disability, which is the second leading cause of death worldwide among them [<xref ref-type="bibr" rid="pone.0210516.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0210516.ref002">2</xref>]. Ischemic stroke is characterized by the partial or complete loss of blood supply in part of the brain tissues and then causes dysfunction which occupies approximately 70–80% of all kinds of strokes [<xref ref-type="bibr" rid="pone.0210516.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0210516.ref003">3</xref>]. So far, when a sudden arterial occlusion occurs, followed by cerebral ischemic stroke, mechanical thrombolysis, and intravenous thrombolysis are the dominating methods to get recanalization, reduce the severity, and improve the outcomes [<xref ref-type="bibr" rid="pone.0210516.ref004">4</xref>]. In addition, sonothrombolysis is a novel method for the treatment of acute ischemic stroke (AIS). Sonothrombolysis by transcranial Doppler (TCD) or transcranial color-coded sonography (TCCS) with or without t-PA is a potential, promising, but debatable, the method for treating AIS patients [<xref ref-type="bibr" rid="pone.0210516.ref005">5</xref>]. Ultrasound can accelerate the blood flow near the thrombus, so we assumed that the application of TCD/TCCS could stir up the blood near the obstructed thrombus [<xref ref-type="bibr" rid="pone.0210516.ref006">6</xref>]. This way can also enhance the mixture of t-PA into a blood and increase the concentration of the t-PA near the occlusion consequently [<xref ref-type="bibr" rid="pone.0210516.ref007">7</xref>]. In addition, the pressure waves produced by TCD/TCCS may also augment the permeation of t-PA into the fibrin network and affect the binding of t-PA with fibrin directly. [<xref ref-type="bibr" rid="pone.0210516.ref008">8</xref>]</p>
<p>Microbubbles are air- or gas-filled microspheres [<xref ref-type="bibr" rid="pone.0210516.ref009">9</xref>] which were initially used to improve the echo-graphic quality of images by increasing the acoustic signal [<xref ref-type="bibr" rid="pone.0210516.ref010">10</xref>]. Application of TCD/TCCS has been shown to cause the vibration of microbubbles, resulting in the microbubbles sustaining absorption of energy until they explode and release the energy [<xref ref-type="bibr" rid="pone.0210516.ref011">11</xref>]. Hence, the ultrasound-induced blast of microbubbles may speed up the dissolution of thrombus. Microbubbles combined with TCD/TCCS were also applied to some other clinical trials, which might be able to get better clinical outcomes [<xref ref-type="bibr" rid="pone.0210516.ref012">12</xref>].</p>
<p>Recent years, there are several trials have consistently illustrated that sonthrombolysis can improve the outcomes of AIS [<xref ref-type="bibr" rid="pone.0210516.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0210516.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0210516.ref017">17</xref>]. Eggers, J., et al. 2005 [<xref ref-type="bibr" rid="pone.0210516.ref014">14</xref>], Eggers, J., et al. 2008 [<xref ref-type="bibr" rid="pone.0210516.ref015">15</xref>] and Dwedar, A.Z., et al. 2014 [<xref ref-type="bibr" rid="pone.0210516.ref016">16</xref>] demonstrated that sonothrombolysis has positive effects on increasing the recanalization rate and improve the clinical outcomes of acute middle cerebral artery occlusion. CLOTBUST 2004 [<xref ref-type="bibr" rid="pone.0210516.ref017">17</xref>] and Molina, C.A., et al. 2006 [<xref ref-type="bibr" rid="pone.0210516.ref009">9</xref>] found that continuous TCD improves t-PA-induced arterial recanalization in patients with AIS, which did not significantly help patients to recover. TUCSON 2009 [<xref ref-type="bibr" rid="pone.0210516.ref013">13</xref>] concluded that ultrasound combined with microbubbles and t-PA showed higher recanalization rates and more favorable outcome rates compared with intravenous t-PA therapy alone. NOR-SASS 2017 [<xref ref-type="bibr" rid="pone.0210516.ref018">18</xref>] revealed that sonothrombolysis is safe, but there is no statistically significant clinical effect in unselected AIS patients.</p>
<p>Based on the above-mentioned clinical studies and trials, the efficacy and safety of sonothrombolysis for AIS are still unclear. There were been some similar systematic reviews that discuss sonothrombolysis in the treatment of AIS [<xref ref-type="bibr" rid="pone.0210516.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0210516.ref019">19</xref>]. However, our work represents an updated of the previous meta-analysis according to the publication of two novel studies in 2014 [<xref ref-type="bibr" rid="pone.0210516.ref016">16</xref>] and 2017 [<xref ref-type="bibr" rid="pone.0210516.ref018">18</xref>]. In addition, the current meta-analysis explores the impact of relevant factors on sonothrombolysis by more comprehensive subgroup analysis.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec003">
<title>Study protocol</title>
<p>This meta-analysis was written according to the preferred reporting items for systematic reviews and PRISMA statement (<xref ref-type="supplementary-material" rid="pone.0210516.s002">S1 File</xref>) [<xref ref-type="bibr" rid="pone.0210516.ref020">20</xref>]. At the start of this project, a drafted study protocol was made to consist with the Cochrane Collaboration format [<xref ref-type="bibr" rid="pone.0210516.ref021">21</xref>].</p>
</sec>
<sec id="sec004">
<title>Eligibility criteria</title>
<p>Inclusion criteria were as follows: (a) Study type: RCT; (b) Language restriction: only English was available; (c) Participants: patients with AIS; (d) Intervention: sonothrombolysis; (e) Outcomes: Efficacy outcomes: excellent functional outcome (modified Rankin Scale (mRS) = 0–1) and good functional outcome (mRS = 0–2) based on mRS, early neurological improvement based on NHISS (NIHSS improve ≥ 4) and recanalization; Safety outcomes: intracranial hemorrhage, death (mRS = 6) and disability (mRS = 3–5). (f) Study years: We searched MEDLINE, EMBASE, and Cochrane Library to find related articles from January 2001 to May 2018. Exclusion criteria were as follows: (a) Study types: case reports, case reviews, retrospective studies, and cohort studies; (b) Control: positive control; (c) Conference abstracts without full text.</p>
</sec>
<sec id="sec005">
<title>Search strategy and information sources</title>
<p>Three major databases: MEDLINE, EMBASE, and Cochrane Library were systematically searched by two authors independently (Z.C. and T.X.). The search strategy of the MEDLINE was to combine all the variables [(“ultrasound” AND “thrombolysis”) OR “sonothrombolysis”] AND “acute ischemic stroke.” Two independent investigators (Z.C. and T.X.) scanned the titles and abstract of all the studies to select applicable studies. The search strategy for EMBASE and the Cochrane Library is similar to what we used for searching MEDLINE. In addition, two investigators (Z.C. and T.X.) manually screened reference lists from RCTs and systematic reviews independently to ensure all relevant studies have been included in this study.</p>
</sec>
<sec id="sec006">
<title>Study selection and data collection</title>
<p>All records from the systematic search in the electronic database and reference lists of RCTs and systematic reviews were evaluated by two authors (Z.C. and T.X.) independently following the eligibility criteria as mentioned above. After strict selection and evaluation, we collect the data from RCTs as follows: basic information on the included trials, inclusion, exclusion criteria for the participants, study design, and outcome assessments (<xref ref-type="table" rid="pone.0210516.t001">Table 1</xref>).</p>
<table-wrap id="pone.0210516.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0210516.t001</object-id>
<label>Table 1</label> <caption><title>Baseline characteristics of the included studies and outcome events in the meta-analysis.</title></caption>
<alternatives>
<graphic id="pone.0210516.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0210516.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Trials</th>
<th align="center">Therapeutic centre</th>
<th align="center">Publication</th>
<th align="center">Inclusion Criteria</th>
<th align="center">Exclusion Criteria</th>
<th align="center">Study Design</th>
<th align="center">Efficacy outcomes</th>
<th align="center">Safety outcomes</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center"><bold>Alexandrov 2004</bold></td>
<td align="center">5 centers in 3 countries</td>
<td align="center"><bold><italic>N Engl J Med</italic></bold></td>
<td align="left">
<list list-type="order">
<list-item><p>NIHSS score ≥ 4;</p></list-item>
<list-item><p>No evidence of hemorrhage;</p></list-item>
<list-item><p>Intravenous tPA infusion initiated within 3 hours of symptom onset;</p></list-item>
<list-item><p>Diagnostic TCD completed before TPA bolus showing arterial occlusion.</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Absent temporal windows;</p></list-item>
<list-item><p>Primary intra-arterial thrombolysis;</p></list-item>
<list-item><p>Patient refusal to give informed consent to participate in the CLOTBUST trial;</p></list-item>
<list-item><p>Standard contraindications for intravenous tPA therapy.</p></list-item>
</list>
</td>
<td align="center">2MHz TCD + tPA vs. tPAc</td>
<td align="left">
<list list-type="order">
<list-item><p>CR in 2 hours</p></list-item>
<list-item><p>Clinical recovery in 2 hours</p></list-item>
<list-item><p>NIHSS scores’ improvement</p></list-item>
<list-item><p>mRS scores at 3 months</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Reocclusion in 2 hours</p></list-item>
<list-item><p>Death and disability at 3 months</p></list-item>
</list>
</td>
</tr>
<tr>
<td align="center"><bold>Eggers 2005</bold></td>
<td align="center">2 centers in 1 country</td>
<td align="center"><bold><italic>Neurology</italic></bold></td>
<td align="left">
<list list-type="order">
<list-item><p>Ischemic stroke in the MCA territory as diagnosed within 6 hours of symptom onset;</p></list-item>
<list-item><p>MCA-M1 occlusion diagnosed by TCCS;</p></list-item>
<list-item><p>Contraindications for IV thrombolytic therapy according to protocol of NINDS rt-PA Stroke Study.</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Thrombolytic therapy if they show EICs greater than one third of the MCA territory;</p></list-item>
<list-item><p>Subjects who met the criteria of the protocol of the NINDS and had EICs in less than one third of the MCA territory.</p></list-item>
</list>
</td>
<td align="center">TCCS vs. none</td>
<td align="left">
<list list-type="order">
<list-item><p>CR, PR, NR in 1 hour and 24 hours</p></list-item>
<list-item><p>NIHSS scores’ improvement at 24 hours and 4 days</p></list-item>
<list-item><p>mRS scores at 3 months</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Death at 3 months and follow-up</p></list-item>
<list-item><p>ICH</p></list-item>
</list>
</td>
</tr>
<tr>
<td align="center"><bold>Molina 2006</bold></td>
<td align="center">6 centers in 3 countries</td>
<td align="center"><bold><italic>Stroke</italic></bold></td>
<td align="left">
<list list-type="order">
<list-item><p>Patients with acute ischemic stroke admitted within the first 3 hours after symptom onset;</p></list-item>
<list-item><p>Patients with a nonlacunar stroke involving the vascular territory of the MCA;</p></list-item>
<list-item><p>Patients underwent urgent carotid US and TCD examinations.</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Insufficient acoustic temporal window or absence of any residual flow in the MCA for TCD examination;</p></list-item>
<list-item><p>Taking anticoagulants, experienced dramatic spontaneous neurological improvement, or showed early signs of infarction&lt; 33% of the MCA territory on baseline CT.</p></list-item>
</list>
</td>
<td align="left">2MHz TCD + tPA +MB vs. 2MHz TCD + tPA vs. tPA alone</td>
<td align="left">
<list list-type="order">
<list-item><p>CR, PR, NR in 2 hours</p></list-item>
<list-item><p>NIHSS scores’ improvement at 24 hours</p></list-item>
<list-item><p>mRS scores at 3 months</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Disability at 3 months</p></list-item>
<list-item><p>ICH</p></list-item>
</list>
</td>
</tr>
<tr>
<td align="center"><bold>Eggers 2008</bold></td>
<td align="center">4 centers in 1 country</td>
<td align="center"><bold><italic>Stroke</italic></bold></td>
<td align="left">
<list list-type="order">
<list-item><p>Ischemic stroke in MCA territory within 3 hours of symptom onset;</p></list-item>
<list-item><p>Early ischemic changes one third or less of the MCA territory;</p></list-item>
<list-item><p>Thrombolytic therapy in accordance with the NINDS;</p></list-item>
<list-item><p>MCA-M1 occlusion diagnosed by TCCS;</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Age &lt;18 years or &gt;80 years;</p></list-item>
<list-item><p>2.Pregnancy or lactation;</p></list-item>
<list-item><p>Premorbid mRS &gt;1;</p></list-item>
<list-item><p>Insufficient acoustic window.</p></list-item>
</list>
</td>
<td align="center">1.8 MHz TCCS + tPA vs. tPA</td>
<td align="left">
<list list-type="order">
<list-item><p>CR, PR, NR in 1 hour and 24 hours</p></list-item>
<list-item><p>NIHSS scores’ improvement at 24 hours and 4 days</p></list-item>
<list-item><p>BI&gt;95 at 3 months</p></list-item>
<list-item><p>mRS scores at 3 months</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Death and disability at 3 months and follow-up</p></list-item>
<list-item><p>ICH</p></list-item>
</list>
</td>
</tr>
<tr>
<td align="center"><bold>Molina 2009</bold></td>
<td align="center">10 centers in 6 countries</td>
<td align="center"><bold><italic>Annals of Neurology</italic></bold></td>
<td align="left">
<list list-type="order">
<list-item><p>All acute (&lt;3 hours) ischemic stroke patients who had a disabling neurological;</p></list-item>
<list-item><p>A proximal intracranial arterial occlusion documented by a TIBI flow score of 0–3 in either the MCA, ACA, ICA, PCA, or top-of-the-distal basilar artery on baseline TCD assessment.</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Evidence of hemorrhage on noncontrast head;</p></list-item>
<list-item><p>Contraindication for intravenous tPA therapy;</p></list-item>
<list-item><p>Primary treatment with intra-arterial thrombolysis;</p></list-item>
<list-item><p>Absent temporal insonation windows;</p></list-item>
<list-item><p>5. Related contraindications</p></list-item>
</list>
</td>
<td align="center">2MHz TCD + tPA + uS vs. tPA</td>
<td align="left">
<list list-type="order">
<list-item><p>CR, PR, NR in 2 hours</p></list-item>
<list-item><p>Clinical recovery in 2 hours</p></list-item>
<list-item><p>mRS scores at 3 months</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Reocclusion in 2 hours</p></list-item>
<list-item><p>Death and disability at 3 months</p></list-item>
<list-item><p>ICH</p></list-item>
</list>
</td>
</tr>
<tr>
<td align="center"><bold>Dwedar 2014</bold></td>
<td align="center">1 center in 1 country</td>
<td align="center"><bold><italic>Neurology India</italic></bold></td>
<td align="left">
<list list-type="order">
<list-item><p>Patients with acute ischemic stroke in the MCA territory within 24 h of onset of symptoms;</p></list-item>
<list-item><p>Age ranging between 40 and 70 years.</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Onset of stroke more than 24h;</p></list-item>
<list-item><p>Poor acoustic window;</p></list-item>
<list-item><p>Patients intolerant to monitoring.</p></list-item>
</list>
</td>
<td align="center">2MHz TCD + aspirin vs. aspirin</td>
<td align="left">
<list list-type="order">
<list-item><p>CR, PR, NR in 1 hour</p></list-item>
<list-item><p>NIHSS scores’ improvement at 24 hours and 7 days</p></list-item>
<list-item><p>MFV changes</p></list-item>
</list>
</td>
<td align="left"/>
</tr>
<tr>
<td align="center"><bold>Nacu 2017</bold></td>
<td align="center">5 centers in 1 country</td>
<td align="center"><bold><italic>Stroke</italic></bold></td>
<td align="left">
<list list-type="order">
<list-item><p>Patients with acute ischaemic stroke, with or without a visible arterial occlusion;</p></list-item>
<list-item><p>Start of treatment within 4.5 hours after stroke onset;</p></list-item>
<list-item><p>Age &gt;18 years.</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Premorbid mRS score ≥ 3;</p></list-item>
<list-item><p>NIHSS cannot be obtained;</p></list-item>
<list-item><p>No visible occlusion;</p></list-item>
<list-item><p>Intracranial haemorrhage;</p></list-item>
<list-item><p>Clinical presentation suggesting subarachnoid haemorrhage;</p></list-item>
<list-item><p>Large areas of hypodense ischaemic changes;</p></list-item>
<list-item><p>Any other serious medical illness likely to interact with treatment.</p></list-item>
</list>
</td>
<td align="center">2Mhz TCD + tPA +MB vs. tPA</td>
<td align="left">
<list list-type="order">
<list-item><p>CR and NR in 24 hours</p></list-item>
<list-item><p>NIHSS scores’ improvement at 24 hours</p></list-item>
<list-item><p>mRS scores at 3 months</p></list-item>
</list>
</td>
<td align="left">
<list list-type="order">
<list-item><p>Death and disability at 3 months and follow-up</p></list-item>
<list-item><p>ICH</p></list-item>
</list>
</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><bold>CLOTBUST</bold>: Combined Lysis Of Thrombus in Brain ischemia Using transcranial ultrasound and Systemic TPA; <bold>TPA</bold>: tissue plasminogen activator; <bold>TCD</bold>: transcranial Doppler; <bold>TIBI</bold>: Thrombolysis In Brain Ischemia; <bold>NIHSS</bold>: National Institute of Health Stroke Scale; <bold>mRS</bold>: modified Rankin scores; <bold>CR</bold>: complete recanalization; <bold>PR</bold>: partial recanalization; <bold>NR</bold>: no recanalization; <bold>NINDS</bold>: National Institute of Neurologic Disorders and Stroke; <bold>EICs</bold>: early ischemic changes; <bold>TCCS</bold>: transcranial color-coded sonography; <bold>MB</bold>: Microbubble; <bold>ICH</bold>: intracerebral hemorrhage; <bold>MCA</bold>: the middle cerebral artery; <bold>ACA</bold>: anterior cerebral artery; <bold>ICA</bold>: internal carotid artery; <bold>PCA</bold>: posterior cerebral artery; <bold>BI</bold>: barthel index; <bold>TUCSON</bold>: Transcranial Ultrasound in Clinical SONothrombolysis; <bold>uS</bold>: Microspheres; <bold>NOR-SASS</bold>: NORwegian Sonothrombolysis in Acute Stroke Study; <bold>MFV</bold>: mean flow velocity.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec007">
<title>Risk of bias</title>
<p>The risk of bias plot in individual studies was created using the Review Manager 5.2 software. Uniform criteria of the Cochrane collaboration we applied to assess the risk of bias of RCTs, including selection bias, performance bias, detection bias, attrition bias, reporting bias, and some other potential biases.</p>
</sec>
<sec id="sec008">
<title>Summary measures and synthesis of results</title>
<p>STATA (Version 12.0) was used for assessing the data. Dichotomous outcomes were analyzed as the risk ratio (relative risk [RR]; 95% confidence interval [CI]) and calculated using a random effect model. Statistical heterogeneity was estimated by the <italic>I</italic><sup>2</sup> statistic as follows: <italic>I</italic><sup>2</sup> &lt; 30% means “low heterogeneity” <italic>I</italic><sup>2</sup> = 30 to 50% denotes “moderate heterogeneity,” and <italic>I</italic><sup>2</sup> &gt; 50% represents “substantial heterogeneity.” Subgroup analyses were implemented to detect the application of microbubble and t-PA, the severity of Stroke, time from onset to treatment and patients’ ages. Sensitivity analysis was used to explore the stability of the consolidated results. Two-tailed test and a P value less than 0.05 was considered significant for all analyses.</p>
</sec>
</sec>
<sec id="sec009" sec-type="results">
<title>Results</title>
<p>Six hundred thirty-eight titles and abstracts were identified through MEDLINE, EMBASE, and Cochrane Library in total (<xref ref-type="fig" rid="pone.0210516.g001">Fig 1</xref>). After removing the duplicates and irrelevant records, 105 articles were included, and 98 articles were excluded because of their types: 23 multiple reports on one RCT, 6 protocol studies, 6 post-hoc analysis, 4 meta-analysis, 5 comments, 32 reviews, and 20 nonrandomized clinical trials. Additionally, 2 conference abstracts without full-text Larrue, V., et al. 2007 [<xref ref-type="bibr" rid="pone.0210516.ref022">22</xref>] and Dinia, L., et al. 2016 [<xref ref-type="bibr" rid="pone.0210516.ref023">23</xref>] were also excluded from the current meta-analysis. Furthermore, the trial of Alexandrov et al. 2008 [<xref ref-type="bibr" rid="pone.0210516.ref024">24</xref>] was excluded due to lose the follow-up information of some patients at three-month (9 out of 15, or 60%) and the data of non-ultrasound control group was the same as CLOTBUST 2004 [<xref ref-type="bibr" rid="pone.0210516.ref017">17</xref>]. Ultimately, seven RCTs [<xref ref-type="bibr" rid="pone.0210516.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0210516.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0210516.ref018">18</xref>] were eligible and contained 549 patients were included in qualitative synthesis (<xref ref-type="fig" rid="pone.0210516.g001">Fig 1</xref>). The main characteristics of those included studies are listed in <xref ref-type="table" rid="pone.0210516.t001">Table 1</xref>.</p>
<fig id="pone.0210516.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0210516.g001</object-id>
<label>Fig 1</label>
<caption>
<title>The study search, selection, and inclusion process.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0210516.g001" xlink:type="simple"/>
</fig>
<sec id="sec010">
<title>Outcomes analysis</title>
<p>All 7 RCTs [<xref ref-type="bibr" rid="pone.0210516.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0210516.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0210516.ref018">18</xref>] include 549 patients are available for the analysis of efficacy and safety outcome.</p>
<sec id="sec011">
<title>1. Efficacy outcome</title>
<p>Sonothrombolysis group has an advantage over the non-sonothrombolysis group for patients in increasing the complete recanalization (RR 2.16, 95% CI 1.51 to 3.08, <italic>P</italic> &lt; 0.001; <xref ref-type="fig" rid="pone.0210516.g002">Fig 2A</xref>), complete or partial recanalization (RR 1.90, 95% CI 1.26 to 2.88, <italic>P</italic> = 0.002; <xref ref-type="fig" rid="pone.0210516.g002">Fig 2B</xref>) and decreasing the no recanalization (RR 0.60, 95% CI 0.49 to 0.73, <italic>P</italic> &lt; 0.001; <xref ref-type="fig" rid="pone.0210516.g002">Fig 2C</xref>). In addition, these was no significant difference between the excellent functional outcome (RR 1.39, 95% CI 0.86 to 2.25, <italic>P</italic> = 0.181; <xref ref-type="fig" rid="pone.0210516.g002">Fig 2D</xref>) and the good functional outcome (RR 1.23, 95% CI 0.88 to 1.73, <italic>P</italic> = 0.229; <xref ref-type="fig" rid="pone.0210516.g002">Fig 2E</xref>), which respectively were defined as the 3-month mRS = 0–1 or 0–2. However, compared with non-sonothrombolysis group, sonothrombolysis group also have a tendency, which can decrease NIHSS score more than 4 in AIS patients (RR 1.43, 95% CI 0.99 to 2.07, <italic>P</italic> = 0.057; <xref ref-type="fig" rid="pone.0210516.g002">Fig 2F</xref>). The heterogeneity test showed significant differences among studies (<italic>I</italic><sup>2</sup> = 60.6%, <italic>P</italic> = 0.038). (<xref ref-type="fig" rid="pone.0210516.g002">Fig 2E</xref>). To detect the source of the statistical heterogeneity, sensitivity analysis was performed. The sensitivity analysis showed that all of the consolidated results were stable (<xref ref-type="supplementary-material" rid="pone.0210516.s001">S1 Fig</xref>).</p>
<fig id="pone.0210516.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0210516.g002</object-id>
<label>Fig 2</label>
<caption>
<title>The pooled relative risk of the efficacy outcomes.</title>
<p>The diamond indicates the estimated relative risk (95% confidence interval) for all patients together. A, Complete recanlization. B, Complete or partial recanlization. C, No recanlization. D, Excellent function outcome. E, Good functional outcome. F, NIHSS improve ≥ 4.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0210516.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec012">
<title>2. Safety outcome</title>
<p>There exist no significant differences in preventing the adverse events, including: ICH (RR 1.02, 95% CI 0.65 to 1.61, <italic>P</italic> = 0.923, <xref ref-type="fig" rid="pone.0210516.g003">Fig 3A</xref>), death or disability (RR 0.83, 95% CI 0.68 to 1.03, <italic>P</italic> = 0.091, <xref ref-type="fig" rid="pone.0210516.g003">Fig 3B</xref>), death (RR 0.89, 95% CI 0.51 to 1.57, <italic>P</italic> = 0.698, <xref ref-type="fig" rid="pone.0210516.g003">Fig 3C</xref>) between sonothrombolysis group and control group.</p>
<fig id="pone.0210516.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0210516.g003</object-id>
<label>Fig 3</label>
<caption>
<title>The pooled relative risk of the safety outcomes.</title>
<p>The diamond indicates the estimated relative risk (95% confidence interval) for all patients together. A, ICH. B, Death or disability. C, Death.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0210516.g003" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec013">
<title>Subgroup analysis</title>
<p>We performed subgroup analyses to assess the utility of microbubbles or t-PA combined with TCD/TCCS, the severity of stroke at the beginning, time of initial treatment and age of patients.</p>
<sec id="sec014">
<title>1. With/without microbubble</title>
<p>The subgroup without microbubble in sonothrombolysis group had a higher rate of excellent functional recovery (RR 1.74, 95% CI 1.00 to 3.01, <italic>P</italic> = 0.049; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>), good functional outcome (RR 1.43, 95% CI 1.03 to 1.99, <italic>P</italic> = 0.032; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>), NIHSS improvement ≥ 4 (RR 1.60, 95% CI 1.09 to 2.36, <italic>P</italic> = 0.017; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>) and simultaneously reduced the statistics of death or disability (RR 0.79, 95% CI 0.65 to 0.95, <italic>P</italic> = 0.011; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>) compared with non-sonothrombolysis group.</p>
<table-wrap id="pone.0210516.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0210516.t002</object-id>
<label>Table 2</label> <caption><title>Subgroup analysis of efficacy and safety outcomes.</title></caption>
<alternatives>
<graphic id="pone.0210516.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0210516.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<tbody>
<tr>
<td align="left" rowspan="3"/>
<td align="center" colspan="6"><bold>Efficacy outcomes</bold></td>
</tr>
<tr>
<td align="center" colspan="2">Excellent functional outcome</td>
<td align="center" colspan="2">Good functional outcome</td>
<td align="center" colspan="2">NIHSS improve ≥ 4</td>
</tr>
<tr>
<td align="center">RR (95% CI)</td>
<td align="center">P value</td>
<td align="center">RR (95% CI)</td>
<td align="center">P value</td>
<td align="center">RR (95% CI)</td>
<td align="center">P value</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>1.use microbubble</bold></td>
</tr>
<tr>
<td align="left">Yes</td>
<td align="center">1.155 (0.637, 2.095)</td>
<td align="center">0.635</td>
<td align="center">1.154 (0.762, 1.747)</td>
<td align="center">0.499</td>
<td align="center">1.267 (0.663, 2.419)</td>
<td align="center">0.474</td>
</tr>
<tr>
<td align="left">No</td>
<td align="center">1.738 (1.002, 3.014)</td>
<td align="center">0.049</td>
<td align="center">1.432 (1.031, 1.988)</td>
<td align="center">0.032</td>
<td align="center">1.600 (1.086, 2.356)</td>
<td align="center">0.017</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>2.use tPA</bold></td>
</tr>
<tr>
<td align="left">Yes</td>
<td align="center">1.349 (0.825, 2.207)</td>
<td align="center">0.233</td>
<td align="center">1.231 (0.877, 1.728)</td>
<td align="center">0.229</td>
<td align="center">1.284 (0.930, 1.771)</td>
<td align="center">0.129</td>
</tr>
<tr>
<td align="left">No</td>
<td align="center">4.444 (0.249, 79.42)</td>
<td align="center">0.311</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">4.661 (1.157, 18.78)</td>
<td align="center">0.030</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>3. Stroke severity at baseline</bold></td>
</tr>
<tr>
<td align="left">NIHSS ≤ 15</td>
<td align="center">1.215 (0.681, 2.167)</td>
<td align="center">0.511</td>
<td align="center">0.967 (0.701, 1.333)</td>
<td align="center">0.838</td>
<td align="center">2.013 (0.556, 7.288)</td>
<td align="center">0.287</td>
</tr>
<tr>
<td align="left">NIHSS &gt; 15</td>
<td align="center">2.081 (0.584, 7.420)</td>
<td align="center">0.259</td>
<td align="center">1.481 (1.081, 2.028)</td>
<td align="center">0.015</td>
<td align="center">1.568 (1.074, 2.290)</td>
<td align="center">0.020</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>4.time to treatment (mins)</bold></td>
</tr>
<tr>
<td align="left">Time ≤ 150</td>
<td align="center">1.720 (1.075, 2.754)</td>
<td align="center">0.024</td>
<td align="center">1.387 (1.007, 1.909)</td>
<td align="center">0.045</td>
<td align="center">1.566 (0.925, 2.650)</td>
<td align="center">0.095</td>
</tr>
<tr>
<td align="left">Time &gt; 150</td>
<td align="center">1.044 (0.494, 2.208)</td>
<td align="center">0.909</td>
<td align="center">1.100 (0.631, 1.920)</td>
<td align="center">0.736</td>
<td align="center">1.480 (0.814, 2.690)</td>
<td align="center">0.199</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>5.Age (years)</bold></td>
</tr>
<tr>
<td align="left">Age ≤ 65</td>
<td align="center">6.185 (0.814, 47.01)</td>
<td align="center">0.078</td>
<td align="center">4.737 (0.611, 36.72)</td>
<td align="center">0.137</td>
<td align="center">2.767 (1.237, 6.187)</td>
<td align="center">0.013</td>
</tr>
<tr>
<td align="left">Age &gt; 65</td>
<td align="center">1.247 (0.809, 1.923)</td>
<td align="center">0.318</td>
<td align="center">1.178 (0.859, 1.616)</td>
<td align="center">0.308</td>
<td align="center">1.211 (0.869, 1.686)</td>
<td align="center">0.258</td>
</tr>
<tr>
<td align="left" rowspan="3"/>
<td align="center" colspan="6"><bold>Safety outcomes</bold></td>
</tr>
<tr>
<td align="center" colspan="2">ICH</td>
<td align="center" colspan="2">Death or disability</td>
<td align="center" colspan="2">Death</td>
</tr>
<tr>
<td align="center">RR (95% CI)</td>
<td align="center">P value</td>
<td align="center">RR (95% CI)</td>
<td align="center">P value</td>
<td align="center">RR (95% CI)</td>
<td align="center">P value</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>1.use microbubble</bold></td>
</tr>
<tr>
<td align="left">Yes</td>
<td align="center">1.064 (0.587, 1.929)</td>
<td align="center">0.838</td>
<td align="center">0.866 (0.517, 1.449)</td>
<td align="center">0.583</td>
<td align="center">0.950 (0.282, 3.197)</td>
<td align="center">0.934</td>
</tr>
<tr>
<td align="left">No</td>
<td align="center">1.027 (0.512, 2.060)</td>
<td align="center">0.940</td>
<td align="center">0.786 (0.653, 0.946)</td>
<td align="center">0.011</td>
<td align="center">0.906 (0.450, 1.826)</td>
<td align="center">0.783</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>2.use tPA</bold></td>
</tr>
<tr>
<td align="left">Yes</td>
<td align="center">1.052 (0.665, 1.663)</td>
<td align="center">0.830</td>
<td align="center">0.835 (0.678, 1.029)</td>
<td align="center">0.091</td>
<td align="center">0.895 (0.501, 1.598)</td>
<td align="center">0.708</td>
</tr>
<tr>
<td align="left">No</td>
<td align="center">0.296 (0.014, 6.292)</td>
<td align="center">0.435</td>
<td align="center">N/A</td>
<td align="center">N/A</td>
<td align="center">0.875 (0.066, 11.54)</td>
<td align="center">0.919</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>3. Stroke severity at baseline</bold></td>
</tr>
<tr>
<td align="left">NIHSS ≤ 15</td>
<td align="center">1.025 (0.293, 3.585)</td>
<td align="center">0.969</td>
<td align="center">1.030 (0.534, 1.986)</td>
<td align="center">0.930</td>
<td align="center">0.872 (0.355, 2.144)</td>
<td align="center">0.765</td>
</tr>
<tr>
<td align="left">NIHSS &gt; 15</td>
<td align="center">1.158 (0.615, 2.183)</td>
<td align="center">0.650</td>
<td align="center">0.766 (0.641, 0.916)</td>
<td align="center">0.003</td>
<td align="center">0.909 (0.439, 1.882)</td>
<td align="center">0.797</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>4.time to treatment (mins)</bold></td>
</tr>
<tr>
<td align="left">Time ≤ 150</td>
<td align="center">1.875 (0.591, 5.947)</td>
<td align="center">0.286</td>
<td align="center">0.770 (0.625, 0.948)</td>
<td align="center">0.014</td>
<td align="center">0.990 (0.489, 2.005)</td>
<td align="center">0.977</td>
</tr>
<tr>
<td align="left">Time &gt; 150</td>
<td align="center">0.916 (0.559, 1.499)</td>
<td align="center">0.726</td>
<td align="center">0.965 (0.548, 1.698)</td>
<td align="center">0.901</td>
<td align="center">0.744 (0.289, 1.919)</td>
<td align="center">0.541</td>
</tr>
<tr>
<td align="left" colspan="7"><bold>5.Age (years)</bold></td>
</tr>
<tr>
<td align="left">Age ≤ 65</td>
<td align="center">1.198 (0.139, 10.32)</td>
<td align="center">0.870</td>
<td align="center">0.780 (0.583, 1.044)</td>
<td align="center">0.095</td>
<td align="center">1.232 (0.303, 5.001)</td>
<td align="center">0.771</td>
</tr>
<tr>
<td align="left">Age &gt; 65</td>
<td align="center">1.004 (0.628, 1.605)</td>
<td align="center">0.987</td>
<td align="center">0.859 (0.644, 1.145)</td>
<td align="center">0.299</td>
<td align="center">0.840 (0.453, 1.559)</td>
<td align="center">0.580</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p><bold>RR</bold>: Relative Risk; <bold>CI</bold>: Confidence Interval; <bold>N/A</bold>: Not Applicable.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>2. With/without t-PA</title>
<p>The subgroup without t-PA in sonothrombolysis group had a more effective NIHSS improvement (RR 4.66, 95% CI 1.16 to 18.78, <italic>P</italic> = 0.030; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>) compared with non-sonothrombolysis group. However, the subgroup with t-PA in sonothrombolysis group might be safer compared with non-sonothrombolysis group by showing a trend towards the attenuation of death or disability (RR 0.84, 95% CI 0.68 to 1.03, <italic>P</italic> = 0.091; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>).</p>
</sec>
<sec id="sec016">
<title>3. NIHSS &gt; 15 / NIHSS ≤ 15 at the beginning of stroke</title>
<p>The high stroke severity subgroup, patients’ NIHSS &gt; 15 at the beginning of stroke in sonothrombolysis group was more likely to get good functional outcome (RR 1.48, 95% CI 1.08 to 2.03, <italic>P</italic> = 0.015; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>) and NIHSS improvement ≥ 4 (RR 1.57, 95% CI 1.07 to 2.29, <italic>P</italic> = 0.020; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>), also had less death or disability (RR 0.77, 95% CI 0.64 to 0.92, <italic>P</italic> = 0.003; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>) compared with non-sonothrombolysis group.</p>
</sec>
<sec id="sec017">
<title>4. Time of the initial treatment &gt; 150min / ≤ 150min</title>
<p>The early treatment subgroup (≤ 150min) in sonothrombolysis group exhibited significantly differences in elevating excellent functional outcome (RR 1.72, 95% CI 1.08 to 2.75, <italic>P</italic> = 0.024; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>), good functional outcome (RR 1.39, 95% CI 1.01 to 1.91, <italic>P</italic> = 0.045; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>) and lowering death or disability (RR 0.77, 95% CI 0.63 to 0.95, <italic>P</italic> = 0.014; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>), compared with non- sonothrombolysis group.</p>
</sec>
<sec id="sec018">
<title>5. Age &gt; 65 years / ≤ 65 years</title>
<p>The patients ≤ 65 years subgroup in sonothrombolysis group were easier to get NIHSS improvement ≥ 4 (RR 2.77, 95% CI 1.24 to 6.19, <italic>P</italic> = 0.013; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>) and a tendency to get more excellent functional outcome (RR 6.19, 95% CI 0.81 to 47, <italic>P</italic> = 0.078; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>) and less death or disability (RR 0.78, 95% CI 0.58 to 1.04, <italic>P</italic> = 0.095; <xref ref-type="table" rid="pone.0210516.t002">Table 2</xref>) compared with non- sonothrombolysis group.</p>
<p>The sensitivity analysis illustrated that all the consolidated statistics are stabilized.</p>
</sec>
</sec>
<sec id="sec019">
<title>Risk of bias in included studies</title>
<p>Details about the risk of bias of the included studies are shown in <xref ref-type="fig" rid="pone.0210516.g004">Fig 4</xref>. For the random sequence generation assessment, the risk of bias was unclear in 3 out of 7 studies. For the allocation concealment assessment, the risk of bias was unclear in 5 out of 7 studies. For the blinding of participants and personnel assessment, the risk of bias of four trial was unclear and 1 out of 7 trial had a high risk of bias. For the blinding of outcomes assessment, the risk of bias was unclear in 2 out of 7 studies. For incomplete outcome data, the risk of bias of 1 out of 7 trial was unclear and 2 out of 7 trials had a high risk of bias. For the selective reporting assessment, the risk of bias was unclear in 1 out of 7 study. There was no high risk, or unclear risk of bias was observed in other items.</p>
<fig id="pone.0210516.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0210516.g004</object-id>
<label>Fig 4</label>
<caption>
<title/>
<p><bold>Risk of bias</bold>: A summary table for each risk of bias item for each study.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0210516.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec020">
<title>Publication bias</title>
<p>The funnel plot was applied to evaluate the publication bias, indicating that there is no evidence for publication bias (<xref ref-type="fig" rid="pone.0210516.g005">Fig 5</xref>). In addition, this evidence is confirmed by a formal statistical test (<bold><italic>P</italic></bold> = 0.967 of Egger’s test).</p>
<fig id="pone.0210516.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0210516.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Begg funnel plot for publication bias test of each study.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0210516.g005" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec021" sec-type="conclusions">
<title>Discussion</title>
<p>Based on the evidence of the current meta-analysis, sonothrombolysis for AIS might be debatable. When it comes to efficacy issues, we found that sonothrombolysis have a distinct benefit on the recanalization of occlusion, increasing the number of complete recanalization of occlusion, increasing complete or partial recanalization, and decreasing the frequency of the no recanalization than non-sonothrombolysis, which was in accordance with most other studies [<xref ref-type="bibr" rid="pone.0210516.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0210516.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0210516.ref014">14</xref>–<xref ref-type="bibr" rid="pone.0210516.ref017">17</xref>, <xref ref-type="bibr" rid="pone.0210516.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0210516.ref025">25</xref>]. Although the specific mechanisms of sonothrombolysis were unclear [<xref ref-type="bibr" rid="pone.0210516.ref026">26</xref>], it has been hypothesized that TCD/TCCS could accelerate the movement of fluid around the thrombus so as to enhance the mixture of t-PA into the blood and consequently elevate the concentration of this drug near the occlusion [<xref ref-type="bibr" rid="pone.0210516.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0210516.ref007">7</xref>]. In addition, the pressure waves produced by TCD/TCCS may also augment the permeation of t-PA into the fibrin network and affect the binding of t-PA with fibrin directly [<xref ref-type="bibr" rid="pone.0210516.ref008">8</xref>]. Moreover, some studies believe that sustainable ultrasound exposure may result in vessel vasodilatation probably owing to the elevation of the activity of nitric oxide synthase, which leads to temporal vasodilation which improved reperfusion of local cerebral tissue [<xref ref-type="bibr" rid="pone.0210516.ref027">27</xref>, <xref ref-type="bibr" rid="pone.0210516.ref028">28</xref>].</p>
<p>When it comes to safety issues, sonothrombolysis or non-sonothrombolysis might not influence the occurrence of ICH, disability or death at 3 months in patients with AIS. The results indicated that sonothrombolysis did not increase the adverse events compared with non-sonothrombolysis. In consideration of the sonothrombolysis hypothetical mechanisms, sonothrombolysis may improve the recanalization in short-term, but 3 months’ outcomes were impacted by more factors such as age, hyperlipidemia, and recurrence of stroke [<xref ref-type="bibr" rid="pone.0210516.ref006">6</xref>, <xref ref-type="bibr" rid="pone.0210516.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0210516.ref027">27</xref>–<xref ref-type="bibr" rid="pone.0210516.ref030">30</xref>]. These factors may lead to the bias of the efficacy and safety results of 3 months’ outcomes, so that we may miss the long-term curative effect of sonothrombolysis.</p>
<p>The subgroup analysis on the basis of microbubbles demonstrated that sonothrombolysis without microbubbles was more effective and safer than non- sonothrombolysis thrombolysis through the subgroup data of excellent functional outcome (<italic>P</italic> = 0.049), good functional outcome (<italic>P</italic> = 0.032), NIHSS improvement ≥ 4 (<italic>P</italic> = 0.017) and death or disability (<italic>P</italic> = 0.011). However, in the sonothrombolysis with microbubbles subgroup, there were no significant differences between sonothrombolysis and non-sonothrombolysis in above mentioned outcome. In theory, the sonothrombolysis plus microbubble therapy should achieve better efficacy than non-sonothrombolysis. However, we got the opposite conclusion according to the sonothrombolysis plus microbubble subgroup anylsis. These results were different from many other articles and trials [<xref ref-type="bibr" rid="pone.0210516.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0210516.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0210516.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0210516.ref031">31</xref>, <xref ref-type="bibr" rid="pone.0210516.ref032">32</xref>] It is possible that only two RCTs nvolve microbubbles, so that a small sample size is difficult to make a difference. In addition, microbubbles were supposed to work by absorbing energy, releasing energy, explosion [<xref ref-type="bibr" rid="pone.0210516.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0210516.ref033">33</xref>] and they might not only accelerate the dissolution of clots [<xref ref-type="bibr" rid="pone.0210516.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0210516.ref035">35</xref>] but also can cause the vascular endothelial damage directly [<xref ref-type="bibr" rid="pone.0210516.ref036">36</xref>]. Therefore, the value of sonothrombolysis plus microbubbles requires more randomized controlled trials to confirm.</p>
<p>Another subgroup analysis, compared with non-sonothrombolysis without t-PA subgroup, sonothrombolysis without t-PA subgroup showed more patients whose NIHSS decrease ≥ 4 (<italic>P</italic> = 0.030). However, when compared sonothrombolysis with t-PA subgroup with non-sonothrombolysis with t-PA subgroup, there is no significant difference in efficacy outcomes. Taken together, we concluded sonothrombolysis is a valuable method to treat AIS and t-PA also play an important role in thrombolysis. Therefore, t-PA is a favorable factor in sonothrombolysis for AIS.</p>
<p>From the rest of subgroup analysis, we found that sonothrombolysis might be more effective and safer for patients whose NIHSS scores at the beginning of the stroke were higher than 15 or the time of initial treatment was less than 150 min or ages were younger than 65 years, compared with non-sonothrombolysis group.</p>
<p>On the basis of our knowledge, most of previous systematic reviews and meta-analysis brought in several non-randomized types of research [<xref ref-type="bibr" rid="pone.0210516.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0210516.ref025">25</xref>, <xref ref-type="bibr" rid="pone.0210516.ref034">34</xref>, <xref ref-type="bibr" rid="pone.0210516.ref037">37</xref>, <xref ref-type="bibr" rid="pone.0210516.ref038">38</xref>]. Combining all the results of no RCTs was heterogeneous so that these systematic reviews were flawed. Different from above-mentioned systematic reviews, all patients in the present meta-analysis were intervened by sonothrombolysis or non-sonothrombolysis and were randomized, which was the best way to divide risk factors equally over the two groups. This is the second meta-analysis about the sonothrombolysis all evidenced from RCTs (randomized clinical trials). In the first article Ricci et al. 2012 [<xref ref-type="bibr" rid="pone.0210516.ref005">5</xref>] included 5 RCTs, and our meta-analysis included 2 relatively novel RCTs, Dwedar et al. 2014 [<xref ref-type="bibr" rid="pone.0210516.ref016">16</xref>] and NOR-SASS 2017 [<xref ref-type="bibr" rid="pone.0210516.ref018">18</xref>], which was not used in preceding systematic reviews and meta-analysis. These two novel RCTs have a large sample size. Besides, we did further subgroup analysis including 5 relevant factors, which provide more comprehensive comparisons between sonothrombolysis and non-sonothrombolysis. With the data from new RCTs [<xref ref-type="bibr" rid="pone.0210516.ref016">16</xref>, <xref ref-type="bibr" rid="pone.0210516.ref018">18</xref>], we might come to more definitive conclusions in order to guide clinical treatment. The following limitations of our meta-analysis should be noticed. Firstly, this meta-analysis was performed on base on the limited statistics. We only pooled 7 published RCTs<sup>15, 19-24</sup> totally 549 patients were included (sonothrombolysis group, n = 302; control group, n = 247) to analysis the efficacy and safety of sonothromblolysis for AIS. Secondly, the included RCTs showed heterogeneity in the data of complete or partial recanalization (<italic>I</italic><sup>2</sup> = 42.2%), excellent functional outcome (<italic>I</italic><sup>2</sup> = 44.1%), good functional outcome (<italic>I</italic><sup>2</sup> = 60.6%) and death or disability (<italic>I</italic><sup>2</sup> = 34.7%). Although the sensitivity analysis demonstrated that all the consolidated statistics were stabilized, these disadvantages of the included studies could not be ignored. Thirdly, there was the possibility of selection bias in our meta-analysis, because we excluded some RCTs only with abstract reported in some meetings like Larrue et al. 2007 [<xref ref-type="bibr" rid="pone.0210516.ref022">22</xref>] and Dinia et al. 2016 [<xref ref-type="bibr" rid="pone.0210516.ref023">23</xref>]. Fourthly, our meta-analysis statistics could not represent all kinds of sonothrombolysis treatment, since we restricted it to TCD/TCCS-induced high-frequency ultrasound treatment (1.8–2 MHz).</p>
<p>In addition to the above limitations, sonothrombolysis itself has limitations in the treatment of AIS. Only patients with occlusion of the proximal middle cerebral artery can benefit significantly by sonothrombolysis. Therefore, the population suitable for treatment is limited. Furthermore, mechanical thrombectomy is currently recommended for the treatment of a large artery occlusion in patients with AIS. Sonothrombolysis is a relatively time consuming and operator-dependent procedure and presents many limitations, mainly technical, according to the presence of a temporal bone window to be performed. However, sonothrombolysis remains a treatment modality when patients admitted to stroke centers without endovascular competence until secondary transport to the intervention center.</p>
</sec>
<sec id="sec022" sec-type="conclusions">
<title>Conclusion</title>
<p>In conclusion, this meta-analysis demonstrated that sonothrombolysis treatment for AIS by TCD/TCCSc had significant efficacy on promoting recanalization and the upward tendency of the number of NIHSS improvement ≥ 4. However, it is not significantly different from other efficacy and safety outcomes. Some factors such as with t-PA, NIHSS &gt; 15, treatment ≤ 150 min and Age ≤ 65 years may be potential advantages of sonothombolysis. These evidences can provide confident insights for further research on sonothombolysis in patients with AIS.</p>
</sec>
<sec id="sec023">
<title>Supporting information</title>
<supplementary-material id="pone.0210516.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0210516.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>The sensitivity analysis of good functional outcome.</title>
<p><xref ref-type="fig" rid="pone.0210516.g002">Fig 2E</xref> sensitivity analysis was performed to detect the source of statistical heterogeneity. which showed that all of the consolidated results were stable.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0210516.s002" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0210516.s002" xlink:type="simple">
<label>S1 File</label>
<caption>
<title>PRISMA 2009 checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank all colleagues who provided us with the information we needed for this study.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0210516.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feigin</surname> <given-names>VL</given-names></name>, <name name-style="western"><surname>Forouzanfar</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Krishnamurthi</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Mensah</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Connor</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bennett</surname> <given-names>DA</given-names></name>, <etal>et al</etal>. <article-title>Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010</article-title>. <source>Lancet</source>. <year>2014</year>;<volume>383</volume>(<issue>9913</issue>):<fpage>245</fpage>–<lpage>54</lpage>. <object-id pub-id-type="pmid">24449944</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Donnan</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Fisher</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Macleod</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davis</surname> <given-names>SM</given-names></name>. <article-title>Stroke</article-title>. <source>Lancet</source>. <year>2008</year>;<volume>371</volume>(<issue>9624</issue>):<fpage>1612</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(08)60694-7" xlink:type="simple">10.1016/S0140-6736(08)60694-7</ext-link></comment> <object-id pub-id-type="pmid">18468545</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adams</surname> <given-names>HP</given-names> <suffix>Jr.</suffix></name>, <name name-style="western"><surname>Bendixen</surname> <given-names>BH</given-names></name>, <name name-style="western"><surname>Kappelle</surname> <given-names>LJ</given-names></name>, <name name-style="western"><surname>Biller</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Love</surname> <given-names>BB</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>DL</given-names></name>, <etal>et al</etal>. <article-title>Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment</article-title>. <source>Stroke</source>. <year>1993</year>;<volume>24</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>41</lpage>. <object-id pub-id-type="pmid">7678184</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McManus</surname> <given-names>JJ</given-names></name>. <article-title>Oxygen consumption of the beetle, Dermestes maculatus</article-title>. <source>Comparative biochemistry and physiology A, Comparative physiology</source>. <year>1974</year>;<volume>49</volume>(<issue>1A</issue>):<fpage>169</fpage>–<lpage>73</lpage>. <object-id pub-id-type="pmid">4153726</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ricci</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Dinia</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Del Sette</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Anzola</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mazzoli</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Cenciarelli</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Sonothrombolysis for acute ischaemic stroke</article-title>. <source>The Cochrane database of systematic reviews</source>. <year>2012</year>;<volume>10</volume>:<fpage>CD008348</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/14651858.CD008348.pub3" xlink:type="simple">10.1002/14651858.CD008348.pub3</ext-link></comment> <object-id pub-id-type="pmid">23076946</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsivgoulis</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Alexandrov</surname> <given-names>AV</given-names></name>. <article-title>Ultrasound-enhanced thrombolysis in acute ischemic stroke: potential, failures, and safety</article-title>. <source>Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics</source>. <year>2007</year>;<volume>4</volume>(<issue>3</issue>):<fpage>420</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.nurt.2007.05.012" xlink:type="simple">10.1016/j.nurt.2007.05.012</ext-link></comment> <object-id pub-id-type="pmid">17599707</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Skoloudik</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Bar</surname> <given-names>M.</given-names></name>, <name name-style="western"><surname>Skoda</surname> <given-names>O.</given-names></name>, <name name-style="western"><surname>Vaclavik</surname> <given-names>D.</given-names></name>, <name name-style="western"><surname>Hradilek</surname> <given-names>R.</given-names></name>, <name name-style="western"><surname>Herzig</surname> <given-names>R.</given-names></name>, &amp; <name name-style="western"><surname>Kanovsky</surname> <given-names>P</given-names></name>. <article-title>Efficacy of sonothrombotripsy versus sonothrombolysis in recanalization of intracranial arteries</article-title>. <source>European Journal of Neurology</source>. <year>2006</year>;<volume>13</volume>:<fpage>1</fpage>. CN-00603701.</mixed-citation></ref>
<ref id="pone.0210516.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alexandrov</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Demchuk</surname> <given-names>A. M.</given-names></name>, <name name-style="western"><surname>Burgin</surname> <given-names>W. S.</given-names></name>, <name name-style="western"><surname>Robinson</surname> <given-names>D. J.</given-names></name>, &amp; <name name-style="western"><surname>Grotta</surname> <given-names>J. C</given-names></name>. <article-title>Ultrasound-Enhanced Thrombolysis for Acute Ischemic Stroke: Phase I. Findings of the CLOTBUST Trial</article-title>. <source>Journal of neuroimaging</source>. <year>2004</year>;<volume>14</volume>(<issue>2</issue>):<fpage>5</fpage>. Epub 2004. CN-00488040.</mixed-citation></ref>
<ref id="pone.0210516.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Molina</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Ribo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rubiera</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Montaner</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Santamarina</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Delgado-Mederos</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator</article-title>. <source>Stroke</source>. <year>2006</year>;<volume>37</volume>(<issue>2</issue>):<fpage>425</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/01.STR.0000199064.94588.39" xlink:type="simple">10.1161/01.STR.0000199064.94588.39</ext-link></comment> <object-id pub-id-type="pmid">16373632</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perren</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Loulidi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Poglia</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Landis</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sztajzel</surname> <given-names>R</given-names></name>. <article-title>Microbubble potentiated transcranial duplex ultrasound enhances IV thrombolysis in acute stroke</article-title>. <source>Journal of thrombosis and thrombolysis</source>. <year>2008</year>;<volume>25</volume>(<issue>2</issue>):<fpage>219</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11239-007-0044-6" xlink:type="simple">10.1007/s11239-007-0044-6</ext-link></comment> <object-id pub-id-type="pmid">17514430</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rubiera</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ribo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Delgado-Mederos</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Santamarina</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Maisterra</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Delgado</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Do bubble characteristics affect recanalization in stroke patients treated with microbubble-enhanced sonothrombolysis?</article-title> <source>Ultrasound in medicine &amp; biology</source>. <year>2008</year>;<volume>34</volume>(<issue>10</issue>):<fpage>1573</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ultrasmedbio.2008.02.011" xlink:type="simple">10.1016/j.ultrasmedbio.2008.02.011</ext-link></comment> <object-id pub-id-type="pmid">18450360</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Auboire</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Sennoga</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Hyvelin</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Ossant</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Escoffre</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Tranquart</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Microbubbles combined with ultrasound therapy in ischemic stroke: A systematic review of in-vivo preclinical studies</article-title>. <source>PloS one</source>. <year>2018</year>;<volume>13</volume>(<issue>2</issue>):<fpage>e0191788</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0191788" xlink:type="simple">10.1371/journal.pone.0191788</ext-link></comment> <object-id pub-id-type="pmid">29420546</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Molina</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Barreto</surname> <given-names>AD</given-names></name>, <name name-style="western"><surname>Tsivgoulis</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Sierzenski</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Malkoff</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Rubiera</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial</article-title>. <source>Annals of neurology</source>. <year>2009</year>;<volume>66</volume>(<issue>1</issue>):<fpage>28</fpage>–<lpage>38</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ana.21723" xlink:type="simple">10.1002/ana.21723</ext-link></comment> <object-id pub-id-type="pmid">19670432</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eggers</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Seidel</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Konig</surname> <given-names>IR</given-names></name>. <article-title>Sonothrombolysis in acute ischemic stroke for patients ineligible for rt-PA</article-title>. <source>Neurology</source>. <year>2005</year>;<volume>64</volume>(<issue>6</issue>):<fpage>1052</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1212/01.WNL.0000154599.45969.D6" xlink:type="simple">10.1212/01.WNL.0000154599.45969.D6</ext-link></comment> <object-id pub-id-type="pmid">15781825</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eggers</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Konig</surname> <given-names>IR</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Handler</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Seidel</surname> <given-names>G</given-names></name>. <article-title>Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study</article-title>. <source>Stroke</source>. <year>2008</year>;<volume>39</volume>(<issue>5</issue>):<fpage>1470</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/STROKEAHA.107.503870" xlink:type="simple">10.1161/STROKEAHA.107.503870</ext-link></comment> <object-id pub-id-type="pmid">18340100</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dwedar</surname> <given-names>AZ</given-names></name>, <name name-style="western"><surname>Ashour</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Haroun</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>El Nasser</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Moustafa</surname> <given-names>RR</given-names></name>, <name name-style="western"><surname>Ibrahim</surname> <given-names>MH</given-names></name>, <etal>et al</etal>. <article-title>Sonothrombolysis in acute middle cerebral artery stroke</article-title>. <source>Neurology India</source>. <year>2014</year>;<volume>62</volume>(<issue>1</issue>):<fpage>62</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4103/0028-3886.128308" xlink:type="simple">10.4103/0028-3886.128308</ext-link></comment> <object-id pub-id-type="pmid">24608457</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alexandrov</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Molina</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Grotta</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Garami</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Ford</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Alvarez-Sabin</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke</article-title>. <source>The New England journal of medicine</source>. <year>2004</year>;<volume>351</volume>(<issue>21</issue>):<fpage>2170</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa041175" xlink:type="simple">10.1056/NEJMoa041175</ext-link></comment> <object-id pub-id-type="pmid">15548777</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nacu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kvistad</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Naess</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Oygarden</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Logallo</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Assmus</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population</article-title>. <source>Stroke</source>. <year>2017</year>;<volume>48</volume>(<issue>2</issue>):<fpage>335</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/STROKEAHA.116.014644" xlink:type="simple">10.1161/STROKEAHA.116.014644</ext-link></comment> <object-id pub-id-type="pmid">27980128</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saqqur</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tsivgoulis</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Nicoli</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Skoloudik</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Sharma</surname> <given-names>VK</given-names></name>, <name name-style="western"><surname>Larrue</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies</article-title>. <source>Journal of neuroimaging: official journal of the American Society of Neuroimaging</source>. <year>2014</year>;<volume>24</volume>(<issue>3</issue>):<fpage>209</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jon.12026" xlink:type="simple">10.1111/jon.12026</ext-link></comment> <object-id pub-id-type="pmid">23607713</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Group</surname> <given-names>P</given-names></name>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source>Bmj</source>. <year>2009</year>;<volume>339</volume>:<fpage>b2535</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.b2535" xlink:type="simple">10.1136/bmj.b2535</ext-link></comment> <object-id pub-id-type="pmid">19622551</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Mulrow</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gotzsche</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Ioannidis</surname> <given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration</article-title>. <source>Bmj</source>. <year>2009</year>;<volume>339</volume>:<fpage>b2700</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.b2700" xlink:type="simple">10.1136/bmj.b2700</ext-link></comment> <object-id pub-id-type="pmid">19622552</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larrue</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Viguier</surname> <given-names>A.</given-names></name>, <name name-style="western"><surname>Arnaud</surname> <given-names>C.</given-names></name>, <name name-style="western"><surname>Cognard</surname> <given-names>C.</given-names></name>, <name name-style="western"><surname>Petit</surname> <given-names>R.</given-names></name>, <name name-style="western"><surname>Rigal</surname> <given-names>M.</given-names></name>, <etal>et al</etal>. <article-title>Trancranial ultrasound combined with intravenous microbubbles and tissue plasminogen activator for acute ischemic stroke: a randomized controlled study</article-title>. <source>Stroke</source>. <year>2007</year>;<volume>38</volume> (<issue>2</issue>):<fpage>1</fpage>. Epub 2007, February. 001.</mixed-citation></ref>
<ref id="pone.0210516.ref023"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Dinia L, Prats-Sánchez L, Carrera D, Delgado-Mederos R, Marín-Bueno R, Camps-Renom P, et al. Sonothrombolysis potentiated by microbubbles in acute ischemic stroke: a prospective randomized pilot study. The 2nd European Stroke Organisation Conference 2016: European Stroke Organisation; 2016. p. 37.</mixed-citation></ref>
<ref id="pone.0210516.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alexandrov</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Mikulik</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ribo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sharma</surname> <given-names>VK</given-names></name>, <name name-style="western"><surname>Lao</surname> <given-names>AY</given-names></name>, <name name-style="western"><surname>Tsivgoulis</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>A pilot randomized clinical safety study of sonothrombolysis augmentation with ultrasound-activated perflutren-lipid microspheres for acute ischemic stroke</article-title>. <source>Stroke</source>. <year>2008</year>;<volume>39</volume>(<issue>5</issue>):<fpage>1464</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/STROKEAHA.107.505727" xlink:type="simple">10.1161/STROKEAHA.107.505727</ext-link></comment> <object-id pub-id-type="pmid">18356546</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsivgoulis</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Eggers</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Ribo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Perren</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Saqqur</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rubiera</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies</article-title>. <source>Stroke</source>. <year>2010</year>;<volume>41</volume>(<issue>2</issue>):<fpage>280</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1161/STROKEAHA.109.563304" xlink:type="simple">10.1161/STROKEAHA.109.563304</ext-link></comment> <object-id pub-id-type="pmid">20044531</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rubiera</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Alexandrov</surname> <given-names>AV</given-names></name>. <article-title>Sonothrombolysis in the management of acute ischemic stroke</article-title>. <source>American journal of cardiovascular drugs: drugs, devices, and other interventions</source>. <year>2010</year>;<volume>10</volume>(<issue>1</issue>):<fpage>5</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2165/11316850-000000000-00000" xlink:type="simple">10.2165/11316850-000000000-00000</ext-link></comment> <object-id pub-id-type="pmid">20104930</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Daffertshofer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hennerici</surname> <given-names>M</given-names></name>. <article-title>Ultrasound in the treatment of ischaemic stroke</article-title>. <source>The Lancet Neurology</source>. <year>2003</year>;<volume>2</volume>(<issue>5</issue>):<fpage>283</fpage>–<lpage>90</lpage>. <object-id pub-id-type="pmid">12849182</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eggers</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Meyer</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Konig</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Seidel</surname> <given-names>G</given-names></name>. <article-title>Effect of ultrasound on thrombolysis of middle cerebral artery occlusion</article-title>. <source>Annals of neurology</source>. <year>2003</year>;<volume>53</volume>(<issue>6</issue>):<fpage>797</fpage>–<lpage>800</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ana.10590" xlink:type="simple">10.1002/ana.10590</ext-link></comment> <object-id pub-id-type="pmid">12783427</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leung</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Leung</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Soo</surname> <given-names>YO</given-names></name>, <name name-style="western"><surname>Mok</surname> <given-names>VC</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>KS</given-names></name>. <article-title>The prognosis of acute symptomatic seizures after ischaemic stroke</article-title>. <source>Journal of neurology, neurosurgery, and psychiatry</source>. <year>2017</year>;<volume>88</volume>(<issue>1</issue>):<fpage>86</fpage>–<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/jnnp-2015-311849" xlink:type="simple">10.1136/jnnp-2015-311849</ext-link></comment> <object-id pub-id-type="pmid">26818728</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Quinn</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Singh</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lees</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Bath</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Myint</surname> <given-names>PK</given-names></name>, <name name-style="western"><surname>Collaborators</surname> <given-names>V</given-names></name>. <article-title>Validating and comparing stroke prognosis scales</article-title>. <source>Neurology</source>. <year>2017</year>;<volume>89</volume>(<issue>10</issue>):<fpage>997</fpage>–<lpage>1002</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1212/WNL.0000000000004332" xlink:type="simple">10.1212/WNL.0000000000004332</ext-link></comment> <object-id pub-id-type="pmid">28794250</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsivgoulis</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Culp</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>Alexandrov</surname> <given-names>AV</given-names></name>. <article-title>Ultrasound enhanced thrombolysis in acute arterial ischemia</article-title>. <source>Ultrasonics</source>. <year>2008</year>;<volume>48</volume>(<issue>4</issue>):<fpage>303</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ultras.2007.11.008" xlink:type="simple">10.1016/j.ultras.2007.11.008</ext-link></comment> <object-id pub-id-type="pmid">18511094</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meairs</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Culp</surname> <given-names>W</given-names></name>. <article-title>Microbubbles for thrombolysis of acute ischemic stroke</article-title>. <source>Cerebrovascular diseases</source>. <year>2009</year>;<volume>27</volume> <issue>Suppl 2</issue>:<fpage>55</fpage>–<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000203127" xlink:type="simple">10.1159/000203127</ext-link></comment> <object-id pub-id-type="pmid">19372661</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schleicher</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Tomkins</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Kampschulte</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hyvelin</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Botteron</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Juenemann</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Sonothrombolysis with BR38 Microbubbles Improves Microvascular Patency in a Rat Model of Stroke</article-title>. <source>PloS one</source>. <year>2016</year>;<volume>11</volume>(<issue>4</issue>):<fpage>e0152898</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0152898" xlink:type="simple">10.1371/journal.pone.0152898</ext-link></comment> <object-id pub-id-type="pmid">27077372</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Saint Victor</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Crake</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Coussios</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>Stride</surname> <given-names>E</given-names></name>. <article-title>Properties, characteristics and applications of microbubbles for sonothrombolysis</article-title>. <source>Expert opinion on drug delivery</source>. <year>2014</year>;<volume>11</volume>(<issue>2</issue>):<fpage>187</fpage>–<lpage>209</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1517/17425247.2014.868434" xlink:type="simple">10.1517/17425247.2014.868434</ext-link></comment> <object-id pub-id-type="pmid">24400730</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Molina</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Alexandrov</surname> <given-names>AV</given-names></name>. <article-title>Transcranial ultrasound in acute stroke: from diagnosis to therapy</article-title>. <source>Cerebrovascular diseases</source>. <year>2007</year>;<volume>24</volume> <issue>Suppl 1</issue>:<fpage>1</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000107373" xlink:type="simple">10.1159/000107373</ext-link></comment> <object-id pub-id-type="pmid">17971633</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wood</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Antony</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gordon</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Hitchins</surname> <given-names>VM</given-names></name>, <etal>et al</etal>. <article-title>Effects of ultrasound and ultrasound contrast agent on vascular tissue</article-title>. <source>Cardiovascular ultrasound</source>. <year>2012</year>;<volume>10</volume>:<fpage>29</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1476-7120-10-29" xlink:type="simple">10.1186/1476-7120-10-29</ext-link></comment> <object-id pub-id-type="pmid">22805356</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Balucani</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Alexandrov</surname> <given-names>AV</given-names></name>. <article-title>Ultrasound- and microspheres-enhanced thrombolysis for stroke treatment: state of the art</article-title>. <source>Current cardiology reports</source>. <year>2010</year>;<volume>12</volume>(<issue>1</issue>):<fpage>34</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s11886-009-0082-0" xlink:type="simple">10.1007/s11886-009-0082-0</ext-link></comment> <object-id pub-id-type="pmid">20425182</object-id>.</mixed-citation></ref>
<ref id="pone.0210516.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amaral-Silva</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pineiro</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Molina</surname> <given-names>CA</given-names></name>. <article-title>Sonothrombolysis for the treatment of acute stroke: current concepts and future directions</article-title>. <source>Expert review of neurotherapeutics</source>. <year>2011</year>;<volume>11</volume>(<issue>2</issue>):<fpage>265</fpage>–<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1586/ern.11.3" xlink:type="simple">10.1586/ern.11.3</ext-link></comment> <object-id pub-id-type="pmid">21306213</object-id>.</mixed-citation></ref>
</ref-list>
</back>
</article>